State Farm Mutual Automobile Insurance
FATE icon

State Farm Mutual Automobile Insurance’s Fate Therapeutics FATE Stock Holding History

State Farm Mutual Automobile Insurance’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28,144
Closed -$494K – 111
2019
Q1 		$494K Buy
+28,144
New +$444K ﹤0.01% 108

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Farm Mutual Automobile Insurance's FATE Position: Q2 2019 in Review

State Farm Mutual Automobile Insurance sold out of Fate Therapeutics (FATE) in Q2 2019, closing a stake of 28,144 shares — an estimated $494K sold.

State Farm Mutual Automobile Insurance first reported a position in FATE in Q1 2019 and held it in 1 quarter. The position peaked at $494K in Q1 2019. 136 funds tracked by Wall St. Rank hold FATE as of Q2 2019.

  • State Farm Mutual Automobile Insurance reported no remaining Fate Therapeutics position as of Q2 2019 after selling out during the quarter.
  • State Farm Mutual Automobile Insurance sold 28,144 Fate Therapeutics shares in Q2 2019, an estimated $494K.
  • State Farm Mutual Automobile Insurance first reported a position in Fate Therapeutics in Q1 2019 and held it in 1 quarter.
  • State Farm Mutual Automobile Insurance's Fate Therapeutics position peaked at $494K in Q1 2019.
  • 136 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2019.

Based on State Farm Mutual Automobile Insurance's 13F filing for Q2 2019, filed 12 Aug 2019.